anifrolumab
astrazeneca
['anifro']
cytosine &amp; indoxin sulfate correlate with baseline measures of kidney damage and shows response (reduction) with anifrolumab treatment. professor david jayne #eular2023 #at
Annals of the Rheumatic Diseases (#1 research journal in Rheumatology) & RMD Open are the official @EULAR_ORG journals. High quality, peer reviewed research.